Overview
1,3-Dimethylamylamine (1,3-DMAA) is a synthetic amine derivative structurally similar to amphetamines. Originally developed as a nasal decongestant in the 1940s, it gained popularity in the 2000s as an ingredient in sports supplements for its stimulant effects. However, regulatory agencies including the FDA and WADA have banned its use in consumer products due to safety concerns. In industrial contexts, 1,3-DMAA is classified as a controlled substance in many jurisdictions. Legitimate commercial use is restricted to pharmaceutical research with proper authorization. The compound is typically supplied as a liquid or hydrochloride salt for laboratory applications.
Physical and Chemical Properties
1,3-DMAA is a volatile liquid with a characteristic amine odor. Its molecular structure features a branched carbon chain with a terminal amine group, contributing to its lipid solubility and central nervous system activity. The compound exhibits moderate stability under standard conditions but may degrade when exposed to light or oxidizing agents. Chemically, 1,3-DMAA behaves as a weak base (pKa ~10.5) and forms salts with acids. Its hydrochloride salt form has better stability for storage. The substance shows limited water solubility but mixes well with organic solvents like ethanol and acetone, making it suitable for certain formulation processes in controlled environments.
Main Applications
Historically, 1,3-DMAA was primarily used in over-the-counter nasal decongestants and bronchodilators under trade names like Forthane. In the early 21st century, it became popular in sports supplements for its ability to increase focus and energy levels, often marketed as a 'natural' stimulant derived from geranium oil - a claim later disproven. Current legitimate applications are strictly limited to research settings, including studies on adrenergic receptors and cardiovascular pharmacology. Some military organizations previously investigated its potential as a performance-enhancing compound, though such uses have been discontinued due to safety concerns.
Safety and Storage
1,3-DMAA presents significant health risks including hypertension, tachycardia, and potential for stroke. The compound should be handled in fume hoods with appropriate PPE (nitrile gloves, lab coat, eye protection). Storage requires airtight containers under inert gas in temperature-controlled environments (15-25°C). Regulatory status varies globally: banned in dietary supplements by FDA (US), prohibited by WADA in sports, and controlled as a prescription drug in many countries. Spills should be contained with absorbent materials and disposed as hazardous waste. First aid measures include fresh air exposure for inhalation and immediate medical attention for ingestion.
B2B Procurement Guide
Legitimate procurement of 1,3-DMAA requires documentation proving research or pharmaceutical manufacturing authorization. Buyers should verify supplier credentials through third-party audits and request current certificates of analysis. Due to regulatory restrictions, international shipments often require special permits. Quality indicators include ≥98% purity (HPLC), proper packaging in amber glass or HDPE containers, and batch-specific documentation. Pricing varies significantly based on quantity (research-scale typically 100g-1kg) and salt form. Alternatives like approved stimulant compounds (e.g., caffeine, synephrine) should be considered for legal formulations.